S02 E04
Surgibots Podcast

Developing Seamless Surgical Robotics Workflows

. On Episode 4 of Season 2 of The Surgibots Podcast I was joined by Edvardas Satkauskas, the CEO and Co-Founder of Inovatyvi Medicina, to talk about the process of developing a seamless clinical workflow through innovative surgical robotic technology. 

Developing Seamless Surgical Robotics Workflows

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
Surgibots S2 Ep 4

Developing Seamless Surgical Robotics Workflows 

When adopting a new piece of technology, it can take surgeons time to adapt. On Episode 4 of Season 2 of The Surgibots Podcast I was joined by Edvardas Satkauskas, the CEO and Co-Founder of Inovatyvi Medicina, to talk about the process of developing a seamless clinical workflow through innovative surgical robotic technology.  

Here are his insights:  

What makes the Sentante platform so ambitious? 

There are two key things about Santana. One is that we designed it to perform entire procedures robotically. That is a big contrast from robotically assisted technology, where physicians are still required to be in the room in order to do the procedure. We designed Santana in such a way that you could do an entire procedure using robots. What that means is that you have the ability to use any endovascular devices or instruments during the procedure, and we are compatible with most standard, off the shelf vascular devices, so physicians can use any devices they are used to during the procedure, but now they can manipulate three devices at a time. So we haven’t changed devices or the clinical workflow - the same people are responsible for doing the same things, except that we have taken the physician out of the operating theatre.  

We haven’t even changed how the physician operates on their own. Santana works because the interface between physician and the robot is the same as the methods they are trained to use. Physicians have an interface with the robot that includes the devices, guide, wire catheter and diagnostic. Whatever the physician does in the cockpit, the robot senses all the movements with linear or rotational movement and translates the exact same movement to the patient side. If there's resistance from the patient, the surgeon can actually feel it in the cockpit through real time haptic force feedback. In that sense, the most ambitious part is that the physician has to retain the ability to feel the resistance of the devices in real time, not just rely on X-ray imaging. That feedback is part of information that doctors base their decisions on while doing the procedure.  

Given that we have to be compatible with a wide range of devices, the system is very dynamic. We have very thin guide wire, which is very sensitive, whereas if you take a very stiff guide wire, where you would use brutal force to get through calcification, those are very different conditions to work in. The system has to be compatible with both of them. It has to provide that haptic force feedback as well as the ability to manipulate the devices as they would be manipulated during medical procedure. Ours is a system that seamlessly integrates into clinical workflow, because physicians can use their existing skills alongside the system after as little as 10 minutes. They don't lose anything, but they gain so much more. 

Is there anything that people haven't liked about Sentante? 

Absolutely. There was some feedback that suggested some improvements, which is actually very difficult in our situation, because we are trying to build a system for endovascular interventions. You can do peripheral interventions, coronary interventions, neuro interventions, and each of those would have very different requirements and very different devices, workflows, and people. Technically, the device can be used in any of those interventions, but our first clinical indication is peripheral vascular, because that's got the shortest time to market for us, and we want to demonstrate the system in a real clinical setting.  

However, we also work with clinicians to demonstrate the system for clinicians that work with neuro indication. For example, with stroke management or aneurysm closing, there are different requirements. There were some very experienced people who initially said, ‘I would probably need more sensitivity, or extreme accuracy,’ and technologically that's absolutely possible, we just need to go that development pathway. The funny thing is that many of the clinicians are usually rather sceptical initially because they see so many technologies every day, but after some time passes, if you demonstrate the system, they come back and say, ‘I thought about it, it's great. That would absolutely work,’ and then we have a great discussion about how we could apply it to their specific field for their specific indication. 

Have you ever had to pivot based on feedback, to the point that you’ve had to change your route or methods? 

We’ve never lost our North Star. We constantly work towards the same requirements that we set at the very beginning, but sometimes we may alter them. We did make some changes to create a better usability. From an engineering standpoint, you can adapt the system or tweak it according to your needs. We could have an equaliser system which would adapt to a particular physicians’ habits for example, but that is a dangerous road to go down, because then you risk making a super complicated system that would need dramatically adjusting to customise it. For some people that would be helpful, but it probably wouldn’t work for everyone. Bringing such a sophisticated system to a clinical work has to be as simple as possible, as easy to use as possible and as safe as possible. We have no room for error. The feedback we collected went into the requirements of the system rather than defining what we’re trying to build.  

To learn more about the Santana system and Edvardas’s work, tune into Season 2, Episode 4 of The Surgibots Podcast.  

 

 

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental
Podcast41

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental

Join host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental. Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics. In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, and why Lupin’s tech could completely transform smile restoration. He also opens up about his medtech philosophy, including why engineers shouldn’t build products alone, and what it really takes to move from zero to launch in a capital-intensive field like robotics. Key Topics Why Paul left surgical robotics for dental robotics The founding story of CMR Surgical The clinical and aesthetic importance of veneers How Lupin reduces a 5-visit dental process into 1 What medtech can learn from AlignTech and Invisalign Building a profitable robot company without hundreds of millions Related Insights Crowns are outdated. Robotic veneers restore enamel with less damage Engineers alone don’t make great products clinicians must co-create One robotic session at Lupin replaces five traditional dental visits India is a strategic first market and a smart regulatory play Fail fast, but never compromise on patient safety Core Challenges Tooth restoration has long been inefficient: dentists rely on hand-guesswork for shaping and prepping teeth. It’s a manual, error-prone process that requires multiple appointments and can cause long-term sensitivity. Lupin Dental solves this with AI-powered planning, CAD design, and a precision robot that prepares the tooth and bonds the veneer all in one session. Tune in now to hear how surgical-grade robotics are reshaping the smile economy and why Lupin Dental could be the next CMR.
Artificial Intelligence Feels Like Magic - With Peter Verrillo
Podcast40

Artificial Intelligence Feels Like Magic - With Peter Verrillo

Meet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI. Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre. Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement. He also emphasises the benefits of working with device-manufacturing companies, as they will take his AI to market under a whitelabel. He states that this relationship is a key part of the medtech industry. Peter also touches on the importance of strong sales reps, suggesting that they should have training in both the software and robotics sides of this new technology in order to efficiently translate it to surgeons.

Discover more about Medical Devices